Home › Funds › Catalio Capital Management, LP › KPTI
Catalio Capital Management, LP position in KPTI
KARYOPHARM THERAPEUTICS INC · Health Care
Catalio Capital Management, LP reported holding 940,855 shares of KPTI (KARYOPHARM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$9.2M, representing 1.73% of its reported portfolio and ranking #22 among its reported holdings. Catalio Capital Management, LP has disclosed KPTI holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's KPTI position evolved
Catalio Capital Management, LP first disclosed a stake in KPTI in Q4 2024 at 2,334,375 shares (US$1.6M). The position peaked in Q2 2026 at 940,855 shares, worth US$9.2M. Across 7 filings, Catalio Capital Management, LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 940,855 shares valued at US$9.2M — an increase of 43,146 shares quarter over quarter.. Notable position changes include a 93% trim in Q1 2025 (shares rose 15% over the following quarter), a 528% increase in Q1 2026 (shares rose 75% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 2.33M | $1.58M | New |
| Q1 2025 | 155.62K | $582.03K | Reduce |
| Q2 2025 | 146.01K | $629.32K | Reduce |
| Q3 2025 | 142.98K | $935.12K | Reduce |
| Q4 2025 | 142.98K | $1.05M | Hold |
| Q1 2026 | 897.71K | $5.00M | Add |
| Q2 2026 | 940.86K | $9.19M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KPTI and 13F data
KPTI (KARYOPHARM THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in KPTI — the largest reported positions include ACORN CAPITAL ADVISORS, LLC (US$14.8M), Avidity Partners Management LP (US$9.0M), Kalehua Capital Management LLC (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KPTI
- ACORN CAPITAL ADVISORS, LLC 1.52M sh · $14.83M · Q2 2026
- Avidity Partners Management LP 924.49K sh · $9.03M · Q2 2026
- Kalehua Capital Management LLC 685.64K sh · $6.70M · Q2 2026
- NEA Management Company, LLC 576.78K sh · $5.64M · Q2 2026
- Tetragon Partners GP Ltd 250.30K sh · $2.45M · Q2 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held KPTI?
Catalio Capital Management, LP has disclosed KPTI holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Catalio Capital Management, LP's current position in KPTI?
As of Q2 2026, Catalio Capital Management, LP holds 940.86K shares of KPTI (KARYOPHARM THERAPEUTICS INC), valued at $9.19M, representing 1.73% of its reported portfolio and ranking #22.
Has Catalio Capital Management, LP been buying or selling KPTI?
In the latest 13F filing (Q2 2026), Catalio Capital Management, LP increased its position in KPTI. The position peaked in Q2 2026 at 940.86K shares.
Which other funds hold KPTI?
Other major institutional holders of KPTI include ACORN CAPITAL ADVISORS, LLC, Avidity Partners Management LP, Kalehua Capital Management LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.